Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Stockholm - Free Realtime Quote SEK

Intervacc AB (publ) (IVACC.ST)

Compare
0.9550
-0.0050
(-0.52%)
As of 9:55:08 AM GMT+1. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
11,787
11,787
8,015
9,684
5,241
Cost of Revenue
15,314
15,314
21,809
6,317
-1,005
Gross Profit
-3,527
-3,527
-13,794
3,367
6,246
Operating Expense
73,750
73,750
79,785
67,780
35,639
Operating Income
-77,277
-77,277
-93,579
-64,413
-29,393
Net Non Operating Interest Income Expense
1,762
1,762
2,115
258
18
Pretax Income
-75,515
-75,515
-91,464
-64,155
-29,375
Tax Provision
--
--
11,388
3
--
Net Income Common Stockholders
-75,515
-75,515
-102,852
-64,158
-29,375
Diluted NI Available to Com Stockholders
-75,515
-75,515
-102,852
-64,158
-29,375
Basic EPS
-0.85
-0.86
-1.36
-1.10
-0.40
Diluted EPS
-0.85
-0.86
-1.36
-1.10
-0.40
Basic Average Shares
101,195.4700
88,280.3770
75,365.2850
58,853.5850
67,318.2050
Diluted Average Shares
101,195.4700
88,280.3770
75,365.2850
58,853.5850
67,645.3260
Total Operating Income as Reported
-77,277
-77,277
-93,579
-64,413
-29,393
Total Expenses
89,064
89,064
101,594
74,097
34,634
Net Income from Continuing & Discontinued Operation
-75,515
-75,515
-102,852
-64,158
-29,375
Normalized Income
-75,515
-75,515
-102,852
-64,158
-29,375
Interest Income
--
--
2,248
383
92
Interest Expense
--
--
133
125
74
Net Interest Income
1,762
1,762
2,115
258
18
EBIT
-77,277
-77,277
-93,579
-64,030
-29,301
EBITDA
-58,747
-58,747
-68,980
-43,172
-23,149
Reconciled Cost of Revenue
15,314
15,314
21,809
6,317
-1,005
Reconciled Depreciation
18,530
18,530
24,599
20,858
6,152
Net Income from Continuing Operation Net Minority Interest
-75,515
-75,515
-102,852
-64,158
-29,375
Normalized EBITDA
-58,747
-58,747
-68,980
-43,172
-23,149
Tax Rate for Calcs
--
--
0.0002
0.0002
--
12/31/2021 - 4/7/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DIABIO.ST Diagonal Bio AB (publ)
0.0162
-5.81%
 
FARN.L Faron Pharmaceuticals Oy
167.50
-1.47%
 
EGTX.ST Egetis Therapeutics AB (publ)
5.06
+0.80%
 
GENO.ST Genovis AB (publ.)
28.85
+1.23%
 
NANOFH.HE Nanoform Finland Oyj
1.2420
+1.64%
 
DMYD-B.ST Diamyd Medical AB (publ)
15.96
+4.72%
 
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
27.20
0.00%
 
SANION.ST Saniona AB (publ)
8.02
+0.25%
 
ONCO.ST Oncopeptides AB (publ)
1.7560
-4.46%
 
FARON.HE Faron Pharmaceuticals Oy
2.0100
-1.23%